CDH1-related diffuse gastric and lobular breast cancer syndrome: genes and variants

CDH1-related diffuse gastric and lobular breast cancer syndrome is linked to 1 analyzed protein (CDH1). 11 DNA variants are known to cause it; 53 more are uncertain, and 0 of those already look disease-causing on computable evidence.

Last updated 2026-09-30. Research information, not medical advice.

Genes linked to CDH1-related diffuse gastric and lobular breast cancer syndrome

Known disease-causing variants in CDH1-related diffuse gastric and lobular breast cancer syndrome

VariantPositionProtein partClinical label
CDH1 M1K1Disease-causing (★★★)
CDH1 M1R1Disease-causing (★★★)
CDH1 M1T1Disease-causing (★★★)
CDH1 M1I1Disease-causing (★★★)
CDH1 M1V1Disease-causing (★★★)
CDH1 G239R239Cadherin 1Disease-causing (★★★)
CDH1 E353K353Cadherin 2Disease-causing (★★★)
CDH1 E336D336Cadherin 2Disease-causing (★★★)
CDH1 T560R560Cadherin 4Disease-causing (★★★)
CDH1 T568R568Cadherin 4Disease-causing (★★★)
CDH1 R732Q732CytoplasmicDisease-causing (★★★)

Which prediction tools work for CDH1-related diffuse gastric and lobular breast cancer syndrome

How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).

Same protein, different disease

Diseases related to CDH1-related diffuse gastric and lobular breast cancer syndrome

Frequently asked questions

Which genes are linked to CDH1-related diffuse gastric and lobular breast cancer syndrome?

In CATVariant, CDH1-related diffuse gastric and lobular breast cancer syndrome is linked to 1 analyzed protein: CDH1 (Cadherin-1).

How many genetic variants are linked to CDH1-related diffuse gastric and lobular breast cancer syndrome?

143 variants: 11 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 53 are of uncertain significance or have conflicting reports.

Which uncertain variants in CDH1-related diffuse gastric and lobular breast cancer syndrome look disease-causing?

None of the uncertain variants currently reaches the likely-pathogenic range on computable evidence alone.

Which variant effect predictor works best for CDH1-related diffuse gastric and lobular breast cancer syndrome?

Among tools not trained on clinical labels, SIFT separates this disease's known disease-causing variants from harmless ones best (AUROC 0.90, based on 10 disease-causing and 120 harmless variants).

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center